Ligand validation:3EH5

BNG: nonyl beta-D-glucopyranoside

BNG is a Ligand Of Interest in 3EH5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3EH5_BNG_A_805	2%	52%	0.351	0.635	0.83	1.02	1	-	2	0	100%	1
3EH5_BNG_C_804	2%	43%	0.385	0.653	0.83	1.43	1	6	0	0	100%	1
3EH5_BNG_A_806	1%	44%	0.399	0.617	1.03	1.18	1	2	0	0	100%	1
3EH5_BNG_A_807	1%	50%	0.371	0.488	0.68	1.23	1	4	0	0	100%	1
1XME_BNG_A_805	5%	36%	0.399	0.808	1.66	0.98	6	1	1	0	100%	1
3EH4_BNG_C_804	2%	23%	0.342	0.633	1.12	2.18	1	6	1	0	100%	1
4RP9_BNG_A_503	84%	70%	0.091	0.952	0.38	0.76	-	-	3	0	100%	1
4MES_BNG_B_201	72%	51%	0.128	0.953	0.83	1.05	-	2	5	0	100%	1
5B0W_BNG_F_304	71%	49%	0.114	0.934	1.25	0.73	3	-	2	0	100%	1
4MUU_BNG_A_202	70%	42%	0.117	0.934	0.85	1.45	-	6	1	0	100%	0.66
4HHR_BNG_A_714	67%	19%	0.098	0.907	0.83	2.76	2	9	1	0	100%	0.381

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.